These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 28441916)
1. Impact of surgical margins on survival of 37 dogs with massive hepatocellular carcinoma. Matsuyama A; Takagi S; Hosoya K; Kagawa Y; Nakamura K; Deguchi T; Takiguchi M N Z Vet J; 2017 Sep; 65(5):227-231. PubMed ID: 28441916 [TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study. Lapsley JM; Wavreille V; Barry S; Dornbusch JA; Chen C; Leeper H; Bertran J; Scavelli D; Liptak JM; Wood C; Shamir S; Rosenbaum C; Montinaro V; Wustefeld-Janssens B; Sterman A; Chik C; Singh A; Collins J; Selmic LE Vet Comp Oncol; 2022 Sep; 20(3):697-709. PubMed ID: 35488436 [TBL] [Abstract][Full Text] [Related]
3. Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002). Liptak JM; Dernell WS; Monnet E; Powers BE; Bachand AM; Kenney JG; Withrow SJ J Am Vet Med Assoc; 2004 Oct; 225(8):1225-30. PubMed ID: 15521445 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007-2018). Moyer J; Lopez DJ; Balkman CE; Sumner JP Open Vet J; 2021; 11(1):144-153. PubMed ID: 33898296 [TBL] [Abstract][Full Text] [Related]
5. Outcomes and prognostic variables associated with central division hepatic lobectomies: 61 dogs. Linden DS; Liptak JM; Vinayak A; Cappelle K; Hoffman C; Fan S; Smiley W; Matz BM Vet Surg; 2019 Apr; 48(3):309-314. PubMed ID: 30663081 [TBL] [Abstract][Full Text] [Related]
6. The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity. Park JH; Kim DH; Kim SH; Kim MY; Baik SK; Hong IS World J Surg; 2018 May; 42(5):1514-1522. PubMed ID: 29026966 [TBL] [Abstract][Full Text] [Related]
7. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs. Kry KL; Boston SE Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683 [TBL] [Abstract][Full Text] [Related]
8. Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis. Shaohua L; Qiaoxuan W; Peng S; Qing L; Zhongyuan Y; Ming S; Wei W; Rongping G PLoS One; 2015; 10(6):e0130021. PubMed ID: 26076461 [TBL] [Abstract][Full Text] [Related]
9. Outcomes following surgical excision or surgical excision combined with adjunctive, hypofractionated radiotherapy in dogs with oral squamous cell carcinoma or fibrosarcoma. Riggs J; Adams VJ; Hermer JV; Dobson JM; Murphy S; Ladlow JF J Am Vet Med Assoc; 2018 Jul; 253(1):73-83. PubMed ID: 29911943 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004). Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of scar revision after inadequate primary excision of cutaneous mast cell tumors in 85 dogs (2000-2013). Karbe GT; Davis E; Runge JJ; Brown DC; Holt DE Vet Surg; 2021 May; 50(4):807-815. PubMed ID: 33666268 [TBL] [Abstract][Full Text] [Related]
12. Central and left division hepatectomies in two dogs. Fontes GS; Piegols HJ; Lapsley JM; Lumbrezer-Johnson SJ; Hostnik ET; Selmic LE J Am Vet Med Assoc; 2023 Oct; 261(10):1-4. PubMed ID: 37339773 [TBL] [Abstract][Full Text] [Related]
13. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714 [TBL] [Abstract][Full Text] [Related]
14. Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma. Zhang J; Zhou ZG; Huang ZX; Yang KL; Chen JC; Chen JB; Xu L; Chen MS; Zhang YJ Chin J Cancer; 2016 Mar; 35():25. PubMed ID: 26956022 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012). Pratschke KM; Atherton MJ; Sillito JA; Lamm CG J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985 [TBL] [Abstract][Full Text] [Related]
18. Influence of surgical margin completeness on risk of local tumour recurrence in canine cutaneous and subcutaneous soft tissue sarcoma: A systematic review and meta-analysis. Milovancev M; Tuohy JL; Townsend KL; Irvin VL Vet Comp Oncol; 2019 Sep; 17(3):354-364. PubMed ID: 30953384 [TBL] [Abstract][Full Text] [Related]
19. [Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma]. Xu L; Shi M; Zhang YQ; Li JQ Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):47-9. PubMed ID: 16737621 [TBL] [Abstract][Full Text] [Related]
20. Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study. Paulos PE; Boston S; Skinner OT; Liptak JM; Amsellem PM; Fournier Q; Wood CJ; Annoni M; Murgia D; Oblak ML; Dean BL; Baird SD; Kulendra NJ Vet Comp Oncol; 2022 Sep; 20(3):669-678. PubMed ID: 35420253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]